XML 16 R6.htm IDEA: XBRL DOCUMENT

A. Basis of Presentation	3 Months Ended
Sep. 30, 2014
Notes to Financial Statements
NOTE A- Basis of Presentation	The condensed balance sheet as of September 30, 2014, the condensed statements of operations for the three month periods ended September 30, 2014 and 2013 and the condensed statements of cash flows for the three month periods ended September 30, 2014 and 2013 have been prepared by PuraMed BioScience, Inc. (the "Company") without audit. In the opinion of management, all adjustments (consisting only of normal recurring accruals) necessary to present fairly the financial position as of September 30, 2014 and the results of operations and cash flows for the three month periods ended September 30, 2014 and 2013 presented herein have been made. Certain information and footnote disclosures normally included in financial statements prepared in accordance with the United States generally accepted accounting principles have been condensed or omitted. These financial statements should be read in conjunction with the Company's financial statements and notes thereto for the fiscal year ended June 30, 2014 included in the Annual Report on Form 10-K of the Company filed with the SEC on October 14, 2014.

A. Basis of Presentation

3 Months Ended

Sep. 30, 2014

The condensed balance sheet as of September 30, 2014, the condensed statements of operations for the three month periods ended September 30, 2014 and 2013 and the condensed statements of cash flows for the three month periods ended September 30, 2014 and 2013 have been prepared by PuraMed BioScience, Inc. (the "Company") without audit. In the opinion of management, all adjustments (consisting only of normal recurring accruals) necessary to present fairly the financial position as of September 30, 2014 and the results of operations and cash flows for the three month periods ended September 30, 2014 and 2013 presented herein have been made.

Certain information and footnote disclosures normally included in financial statements prepared in accordance with the United States generally accepted accounting principles have been condensed or omitted. These financial statements should be read in conjunction with the Company's financial statements and notes thereto for the fiscal year ended June 30, 2014 included in the Annual Report on Form 10-K of the Company filed with the SEC on October 14, 2014.